These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 10223780

  • 21. Prevention of recurrent lone atrial fibrillation by the angiotensin-II converting enzyme inhibitor ramipril in normotensive patients.
    Belluzzi F, Sernesi L, Preti P, Salinaro F, Fonte ML, Perlini S.
    J Am Coll Cardiol; 2009 Jan 06; 53(1):24-9. PubMed ID: 19118720
    [Abstract] [Full Text] [Related]

  • 22. Effects of graded-release diltiazem versus ramipril, dosed at bedtime, on early morning blood pressure, heart rate, and the rate-pressure product.
    White WB, Lacourciere Y, Gana T, Pascual MG, Smith DH, Albert KS.
    Am Heart J; 2004 Oct 06; 148(4):628-34. PubMed ID: 15459593
    [Abstract] [Full Text] [Related]

  • 23. Effect of angiotensin receptor blockade on systemic right ventricular function and size: a small, randomized, placebo-controlled study.
    Therrien J, Provost Y, Harrison J, Connelly M, Kaemmerer H, Webb GD.
    Int J Cardiol; 2008 Sep 26; 129(2):187-92. PubMed ID: 18672299
    [Abstract] [Full Text] [Related]

  • 24. Utility of semiautomatic clinic and 24-h ambulatory blood pressure measurements to evaluate combination therapy: the Ramipril-Hydrochlorothiazide Hypertension trial.
    White WB, Cleveland JM, Rolleri RL, Ramipril-Hydrochlorothiazide Study Group.
    J Hum Hypertens; 2008 Aug 26; 22(8):559-68. PubMed ID: 18463672
    [Abstract] [Full Text] [Related]

  • 25. The PHARAO study: prevention of hypertension with the angiotensin-converting enzyme inhibitor ramipril in patients with high-normal blood pressure: a prospective, randomized, controlled prevention trial of the German Hypertension League.
    Lüders S, Schrader J, Berger J, Unger T, Zidek W, Böhm M, Middeke M, Motz W, Lübcke C, Gansz A, Brokamp L, Schmieder RE, Trenkwalder P, Haller H, Dominiak P, PHARAO Study Group.
    J Hypertens; 2008 Jul 26; 26(7):1487-96. PubMed ID: 18551027
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Comparison of the effect of valsartan and lisinopril on autonomic nervous system activity in chronic heart failure.
    De Tommasi E, Iacoviello M, Romito R, Ceconi C, Guida P, Massari F, Francolini G, Bertocchi F, Ferrari R, Rizzon P, Pitzalis MV.
    Am Heart J; 2003 Nov 26; 146(5):E17. PubMed ID: 14597946
    [Abstract] [Full Text] [Related]

  • 28. Bradykinin contributes to the systemic hemodynamic effects of chronic angiotensin-converting enzyme inhibition in patients with heart failure.
    Cruden NL, Witherow FN, Webb DJ, Fox KA, Newby DE.
    Arterioscler Thromb Vasc Biol; 2004 Jun 26; 24(6):1043-8. PubMed ID: 15105283
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Comparative efficacy and safety of aliskiren, an oral direct renin inhibitor, and ramipril in hypertension: a 6-month, randomized, double-blind trial.
    Andersen K, Weinberger MH, Egan B, Constance CM, Ali MA, Jin J, Keefe DL.
    J Hypertens; 2008 Mar 26; 26(3):589-99. PubMed ID: 18300872
    [Abstract] [Full Text] [Related]

  • 32. Quinapril ACE-inhibition effects on adrenergic parameters in moderate essential hypertension.
    Vallès Prats M, Matas Serra M, Bronsoms Artero J, Matè Benito G, Torguet Escuder P, Mauri Nicolas JM.
    Kidney Int Suppl; 1996 Jun 26; 55():S104-6. PubMed ID: 8743525
    [Abstract] [Full Text] [Related]

  • 33. On the existence of functional beta-adrenoceptors on vascular sympathetic nerve endings in the human forearm.
    Chang PC, Grossman E, Kopin IJ, Goldstein DS.
    J Hypertens; 1994 Jun 26; 12(6):681-90. PubMed ID: 7963493
    [Abstract] [Full Text] [Related]

  • 34. Converting enzyme inhibition attenuates the noradrenaline response to the Valsalva maneuvre.
    Fernandez PG, Snedden W.
    Can J Cardiol; 1991 Jun 26; 7(5):214-22. PubMed ID: 1860093
    [Abstract] [Full Text] [Related]

  • 35. Effects of antihypertensive therapies on the sympathetic nervous system.
    de Champlain J, Karas M, Toal C, Nadeau R, Larochelle P.
    Can J Cardiol; 1999 Mar 26; 15 Suppl A():8A-14A. PubMed ID: 10205251
    [Abstract] [Full Text] [Related]

  • 36. Pharmacologic tools for assessment of adrenergic nerve activity in human hypertension.
    Ibsen H, Julius S.
    Fed Proc; 1984 Jan 26; 43(1):67-71. PubMed ID: 6317465
    [Abstract] [Full Text] [Related]

  • 37. [The effect of ramipril on metabolic, renal and cardiac function in hypertension and type II diabetes mellitus].
    Vítovec J, Spinar J.
    Vnitr Lek; 1998 Jun 26; 44(6):336-41. PubMed ID: 9820056
    [Abstract] [Full Text] [Related]

  • 38. Effects of Ramipril and Isradipin on hemorheological profiles in patients with arterial hypertension.
    Muravyov AV, Zaitsev LG, Muravyov AA, Yakusevich VV, Sirotkina AM.
    Clin Hemorheol Microcirc; 1998 Jul 26; 18(2-3):185-90. PubMed ID: 9699040
    [Abstract] [Full Text] [Related]

  • 39. [A comparison of the effect of Capoten (captopril) and ramipril on the circadian profile of the arterial pressure and peripheral hemodynamics in patients with hypertension combined with diabetes mellitus].
    Filatova EV, Vikhert OA, Rogoza AN, Arabidze GG, Kukharchuk VV.
    Ter Arkh; 1996 Jul 26; 68(5):67-70. PubMed ID: 9082606
    [Abstract] [Full Text] [Related]

  • 40. Effects of Angiotensin-Converting Enzyme Inhibition and Alpha 1-Adrenergic Receptor Blockade on Inflammation and Hemostasis in Human Hypertension.
    Ekholm M, Jekell A, Wallén NH, Gigante B, Kahan T.
    J Cardiovasc Pharmacol; 2018 Apr 26; 71(4):240-247. PubMed ID: 29389738
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.